Safety and Efficacy of Systemic Allogenic NK Cells in R/R Neuroblastoma

Clinical trial NCT06674265 · RECRUITING

Trial details

NCT number: NCT06674265
Sponsor: Marzieh Ebrahimi
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Neuroblastoma, Recurrent, Refractory Neuroblastoma (NB)Neuroblastoma in Children

Start date: 2024-11-10
Primary completion: 2026-11-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.